Literature DB >> 32043399

Why do people use new psychoactive substances? Development of a new measurement tool in six European countries.

Annemieke Benschop1, Róbert Urbán2, Máté Kapitány-Fövény3,4, Marie Claire Van Hout5, Katarzyna Dąbrowska6, Katalin Felvinczi2, Evelyn Hearne5, Susana Henriques7,8, Zsuzsa Kaló2, Gerrit Kamphausen9, Joana Paula Silva8, Łukasz Wieczorek6, Bernd Werse9, Michal Bujalski6, Dirk Korf1, Zsolt Demetrovics2.   

Abstract

INTRODUCTION: New psychoactive substances (NPS) pose a public health threat. Many studies have tried to identify the reasons of NPS use; however, none of them have so far used any standardised measures. The aim of this study was (i) to develop and cross-culturally validate the New Psychoactive Substance Use Motives Measure (NPSMM) and (ii) to compare motives of NPS use across countries and user types.
METHODS: Three subgroups (socially marginalised users, nightlife attendees and members of online communities) of NPS users (N = 3023) were recruited from six EU member countries. Demographics, motives and types of NPS used were assessed. NPS use motives were measured by adapting the extended six-factor version of the Marijuana Motives Measure.
RESULTS: Exploratory and confirmatory factor analysis resulted in a similar five-factor solution across most of the countries: coping, enhancement, social, conformity and expansion motives. Marginalised users scored higher on coping and conformity motives, nightlife groups showed higher endorsement of social motive, whereas online community users showed higher scores on expansion motives. Various types of NPS were also associated with different motives.
CONCLUSION: NPS use motives might be associated with both the groups of users and the specific types of NPS being consumed. Expansion (psychedelics) and enhancement (stimulants) motives seemed to be linked to the chosen NPS product type, while coping, social and conformity motives were rather associated with user groups. NPSMM was found to be a valid instrument to measure NPS motives.

Entities:  

Keywords:  New psychoactive substances; cross-national validation; measurement; motives of substance use

Mesh:

Substances:

Year:  2020        PMID: 32043399     DOI: 10.1177/0269881120904951

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  2 in total

1.  Awareness of users and motivational factors for using new psychoactive substances in Belgium.

Authors:  Sarah Simonis; Michaël Canfyn; Anton Van Dijck; Tina Van Havere; Eric Deconinck; Peter Blanckaert; Lies Gremeaux
Journal:  Harm Reduct J       Date:  2020-07-25

2.  Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.

Authors:  Jessica Neicun; Justin Christopher Yang; Hueyjong Shih; Pranay Nadella; Robin van Kessel; Attilio Negri; Kasia Czabanowska; Carol Brayne; Andres Roman-Urrestarazu
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.